BiomX investor group discloses 20.4% stake
BiomX Inc. received a significant new shareholder group disclosure, with Water IO Ltd., Star 26 Capital Inc., T3 Defense Inc. and Menachem Shalom reporting sizeable stakes in its common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BiomX Inc. received a significant new shareholder group disclosure, with Water IO Ltd., Star 26 Capital Inc., T3 Defense Inc. and Menachem Shalom reporting sizeable stakes in its common stock.
Water IO acquired 1,300,000 shares of BiomX common stock as part of a Stock Purchase Agreement under which BiomX bought 100% of Zorronet in exchange for those shares plus a non-convertible promissory note of $1,250,000. No cash was used by the reporting entities for this equity consideration.
Menachem Shalom, CEO and director of T3 Defense, holds 1,600,000 shares, or 20.4% of BiomX on a fully diluted basis, including 300,000 shares he owns directly. He personally purchased 100,000 shares at $5.00 per share and 200,000 shares at $6.00 per share from an affiliate of BiomX, using personal savings. Each of Water IO, Star 26 and T3 Defense reports beneficial ownership of 1,300,000 shares, or 16.57% of BiomX on a fully diluted basis, with shared voting and dispositive power over those shares.
Insights
New investor group reports a concentrated 20.4% stake in BiomX via equity-for-acquisition and direct purchases.
The filing shows Water IO, Star 26, T3 Defense and Menachem Shalom as a coordinated holder group in BiomX. Water IO exchanged Zorronet’s equity for 1,300,000 BiomX shares plus a $1,250,000 non-convertible note under an April 2026 Stock Purchase Agreement.
On a fully diluted basis, each of Water IO, Star 26 and T3 Defense reports 16.57% beneficial ownership, while Menachem Shalom reports 20.4%, including 300,000 shares held directly. This concentration may increase this group’s influence over shareholder decisions, although actual impact will depend on broader ownership and future voting outcomes as disclosed in subsequent filings.
Key Figures
Key Terms
beneficially owned financial
fully-diluted basis financial
Stock Purchase Agreement financial
non-convertible promissory note financial
Schedule 13D regulatory
Reporting Person regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in BiomX Inc. (PHGE) does Menachem Shalom report in this Schedule 13D/A amendment?
What percentage of BiomX Inc. (PHGE) does each entity in the reporting group beneficially own?
What type of consideration did BiomX Inc. provide in the Zorronet acquisition referenced in the PHGE Schedule 13D/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.